Riparian Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
201 Dexter Ave, Watertown, Massachusetts...Phone Number
(617) 398-7784Website
www.riparianpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Riparian Pharmaceuticals
Riparian Pharmaceuticals is focused on discovering novel therapeutics aimed at reversing endothelial dysfunction and enhancing human vascular health. The company is dedicated to addressing vascular health challenges through innovative treatments. Its intended clients include healthcare providers and patients seeking advanced solutions for vascular conditions. Riparian's research emphasizes the importance of endothelial function in overall cardiovascular wellness.Explore more
Riparian Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Riparian Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Riparian Pharmaceuticals had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Riparian Pharmaceuticals has new funding data
Check out if Riparian Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Riparian Pharmaceuticals
Earning: See what the market has to say on Riparian Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Riparian Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Riparian Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Riparian Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Riparian Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Riparian Pharmaceuticals
Compare insights from companies similar to Riparian Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Riparian Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Riparian Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Riparian Pharmaceuticals.
Riparian Pharmaceuticals financials insights
Gather financial insights about Riparian Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$67K
Riparian Pharmaceuticals Tech Stack
A closer look at the technologies used by Riparian Pharmaceuticals
Riparian Pharmaceuticals News & Media
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research agreement with Pfizer. In exchange for exclusive rights to a Riparian preclinical program, Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics. As pViva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and...Riparian Pharmaceuticals Announces Agreements with Pfizer for Novel Cardiovascular Programs
WATERTOWN, Mass.--(BUSINESS WIRE)--Riparian Pharmaceuticals, a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases, today announced it has entered into an exclusive license agreement and research agreement with Pfizer. In exchange for exclusive rights to a Riparian preclinical program, Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics. As part of the research agreement, Pfizer will support Riparia
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Riparian Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Riparian Pharmaceuticals is focused on discovering novel therapeutics aimed at reversing endothelial dysfunction and enhancing human vascular health. The company is dedicated to addressing vascular health challenges through innovative treatments. Its intended clients include healthcare providers and patients seeking advanced solutions for vascular... Read More
